Rapid drug desensitization for platinum‐based chemotherapy drugs significantly increases peripheral blood IL‐10 levels von Tüzer, Can, Sari, Murat, Aktaş Çetin, Esin, Ak, Naziye, Büyüköztürk, Suna, Çolakoğlu, Bahattin, Mualla Saip, Pınar, Deniz, Günnur, Gelincik, Aslı

Volltext

New biomarkers in peripheral blood of patients with ovarian cancer: high expression levels of miR-16-5p, miR-17-5p, and miR-638 von Saral, Mukaddes Avsar, Tuncer, Seref Bugra, Odemis, Demet Akdeniz, Erdogan, Ozge Sukruoglu, Erciyas, Seda Kilic, Saip, Pınar, Ozel, Sevda, Yazici, Hulya

Volltext

Congratulations to the journal of oncological sciences von Saip, Pınar

Volltext

TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer von Cabioglu, Neslihan, Onder, Semen, Oner, Gizem, Karatay, Huseyin, Tukenmez, Mustafa, Muslumanoglu, Mahmut, Igci, Abdullah, Eralp, Yesim, Aydiner, Adnan, Saip, Pinar, Yavuz, Ekrem, Ozmen, Vahit

Volltext

Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurr... von Ünal, Çağlar, Özmen, Tolga, Ordu, Çetin, Pilanci, Kezban Nur, İlgün, Ahmet Serkan, Gökmen, Erhan, Almuradova, Elvina, Özdoğan, Mustafa, Güler, Nilüfer, Uras, Cihan, Kara, Halil, Demircan, Orhan, Işık, Selver, Alço, Gül, Saip, Pınar, Aydın, Esra, Duymaz, Tomris, Çelebi, Filiz, Yararbaş, Kanay, Soybir, Gursel, Ozmen, Vahit

Volltext

Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression von Dogan, Izzet, Aydin, Esra, Khanmammadov, Nijat, Paksoy, Nail, Saip, Pinar, Aydiner, Adnan

Volltext

Eribulin monotherapy in heavily pretreated metastatic breast cancer patients in real life von Sari, Murat, Saip, Pınar

Volltext

Central nervous system metastasis in gynecologic cancers: Seeking the prognostic factors von Minareci, Yagmur, Ak, Naziye, Tosun, Ozgur Aydın, Sozen, Hamdullah, Saip, Pinar Mualla, Topuz, Samet, Salihoglu, Mehmet Yavuz

Volltext

Outcomes of the patients with metastatic male breast cancer von Dogan, Izzet, Khanmammadov, Nijat, Ozkurt, Selnur, Aydiner, Adnan, Saip, Pinar

Volltext

Abstract PS14-25: Outcomes of metastatic male breast cancer von Dogan, Izzet, Khanmammadov, Nijat, Aydıner, Adnan, Saip, Pınar

Volltext

Abstract PS10-44: Termination of trastuzumab-based treatment after complete response in HER2-positive metastatic breast cancer von Dogan, Izzet, Aydın, Esra, Khanmammadov, Nijat, Aydıner, Adnan, Saip, Pınar

Volltext

Abstract PS14-26: Comparison of clinicopathological features in BRCA-wild type and -mutated male breast cancer patients von Dogan, Izzet, Aydın, Esra, Yazıcı, Hülya, Saip, Pınar

Volltext

Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer? von Celik, Engin, Kizildag Yirgin, Inci, Goksever Celik, Hale, Engin, Gulgun, Sozen, Hamdullah, Ak, Naziye, Saip, Pınar, Onder, Semen, Topuz, Samet, Salihoglu, Mehmet Y.

Volltext

Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial von Demir, Atakan, Mandel, Nil Molinas, Paydas, Semra, Demir, Gokhan, Er, Ozlem, Turhal, Nazim Serdal, Bavbek, Sevil, Eralp, Yesim, Saip, Pinar Mualla, Guler, Emine Nilufer, Aydiner, Adnan, Uluc, Basak Oyan, Kilickap, Sadettin, Uskent, Necdet, Karadurmus, Nuri, Kaplan, Mehmet Ali, Yanmaz, Mustafa Teoman, Demir, Hacer, Alan, Ozkan, Korkmaz, Taner, Olgun, Polat, Uysal, Ozlem Sonmez, Altundag, Kadri, Gunduz, Seyda, Gunaldi, Meral, Sari, Murat, Beypinar, Ismail, Basaran, Gul

Volltext

Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine von Doğan, İzzet, Paksoy, Nail, Ak, Naziye, Vatansever, Sezai, Saip, Pınar, Aydıner, Adnan

Volltext

Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer von Ciftci, Rumeysa, Tas, Faruk, Bilgin, Elif, Keskin, Serkan, Yildiz, Ibrahim, Duranyildiz, Derya, Saip, Pınar, Karanlik, Hasan, Vatansever, Sezai

Volltext

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors von Dogan, Izzet, Khanmammadov, Nijat, Yıldız, Anıl, Ahmed, Melin Aydan, Vatansever, Sezai, Saip, Pinar, Aydiner, Adnan

Volltext

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer von Cabioglu, Neslihan, Bayram, Aysel, Emiroglu, Selman, Onder, Semen, Karatay, Huseyin, Oner, Gizem, Tukenmez, Mustafa, Muslumanoglu, Mahmut, Igci, Abdullah, Aydiner, Adnan, Saip, Pinar, Yavuz, Ekrem, Ozmen, Vahit

Volltext

Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG) von İçli, Fikri, Altundağ, Kadri, Akbulut, Hakan, Paydaş, Semra, Başaran, Gül, Saip, Pınar, Doğu, Gamze G., Eralp, Yeşim, Uslu, Rüçhan, Sevinç, Alper, Onur, Handan, Mandel, Nil M., Sezgin, Canfeza, Altınbaş, Mustafa, Güler, Nilüfer, Işıkdoğan, Abdurrahman, Gökmen, Erhan, Uygun, Kazım, Üstüner, Zeki, Yaren, Arzu, Demirkan, Binnaz, Coşkun, Uğur, Ata, Alper, Özkan, Metin, Arican, Ali

Volltext

Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients von Doğan, İzzet, Aydın, Esra, Yazıcı, Hülya, Saip, Pınar

Volltext